REPORT ID 20405

Global Drugs for Diabetic Macular Edema Market Research Report 2016

Publish Date
14-Oct
Pages
119
Format
Electronic (PDF)

Notes:
Production, means the output of Drugs for Diabetic Macular Edema
Revenue, means the sales value of Drugs for Diabetic Macular Edema

This report studies Drugs for Diabetic Macular Edema in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
    Roche
    Pfizer
    Genentech
    ActiveSite Pharmaceuticals
    Acucela
    Aerpio Therapeutics
    Allergan
    Ampio Pharmaceuticals
    Dyax
    EyeGate Pharmaceuticals
    Gene Signal International
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Drugs for Diabetic Macular Edema in these regions, from 2011 to 2021 (forecast), like
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
    Lucentis
    Eylea
    Avastin
Split by application, this report focuses on consumption, market share and growth rate of Drugs for Diabetic Macular Edema in each application, can be divided into
    Application 1
    Application 2
    Application 3

 
			   
Table of Contents

Global Drugs for Diabetic Macular Edema Market Research Report 2016
1 Drugs for Diabetic Macular Edema Market Overview
    1.1 Product Overview and Scope of Drugs for Diabetic Macular Edema
    1.2 Drugs for Diabetic Macular Edema Segment by Type
        1.2.1 Global Production Market Share of Drugs for Diabetic Macular Edema by Type in 2015
        1.2.2 Lucentis
        1.2.3 Eylea
        1.2.4 Avastin
    1.3 Drugs for Diabetic Macular Edema Segment by Application
        1.3.1 Drugs for Diabetic Macular Edema Consumption Market Share by Application in 2015
        1.3.2 Application 1
        1.3.3 Application 2
        1.3.4 Application 3
    1.4 Drugs for Diabetic Macular Edema Market by Region
        1.4.1 North America Status and Prospect (2011-2021)
        1.4.2 Europe Status and Prospect (2011-2021)
        1.4.3 China Status and Prospect (2011-2021)
        1.4.4 Japan Status and Prospect (2011-2021)
        1.4.5 Southeast Asia Status and Prospect (2011-2021)
        1.4.6 India Status and Prospect (2011-2021)
    1.5 Global Market Size (Value) of Drugs for Diabetic Macular Edema (2011-2021)

2 Global Drugs for Diabetic Macular Edema Market Competition by Manufacturers
    2.1 Global Drugs for Diabetic Macular Edema Capacity, Production and Share by Manufacturers (2015 and 2016)
    2.2 Global Drugs for Diabetic Macular Edema Revenue and Share by Manufacturers (2015 and 2016)
    2.3 Global Drugs for Diabetic Macular Edema Average Price by Manufacturers (2015 and 2016)
    2.4 Manufacturers Drugs for Diabetic Macular Edema Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Drugs for Diabetic Macular Edema Market Competitive Situation and Trends
        2.5.1 Drugs for Diabetic Macular Edema Market Concentration Rate
        2.5.2 Drugs for Diabetic Macular Edema Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Drugs for Diabetic Macular Edema Capacity, Production, Revenue (Value) by Region (2011-2016)
    3.1 Global Drugs for Diabetic Macular Edema Capacity and Market Share by Region (2011-2016)
    3.2 Global Drugs for Diabetic Macular Edema Production and Market Share by Region (2011-2016)
    3.3 Global Drugs for Diabetic Macular Edema Revenue (Value) and Market Share by Region (2011-2016)
    3.4 Global Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
    3.5 North America Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
    3.6 Europe Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
    3.7 China Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
    3.8 Japan Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
    3.9 Southeast Asia Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
    3.10 India Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Drugs for Diabetic Macular Edema Supply (Production), Consumption, Export, Import by Regions (2011-2016)
    4.1 Global Drugs for Diabetic Macular Edema Consumption by Regions (2011-2016)
    4.2 North America Drugs for Diabetic Macular Edema Production, Consumption, Export, Import by Regions (2011-2016)
    4.3 Europe Drugs for Diabetic Macular Edema Production, Consumption, Export, Import by Regions (2011-2016)
    4.4 China Drugs for Diabetic Macular Edema Production, Consumption, Export, Import by Regions (2011-2016)
    4.5 Japan Drugs for Diabetic Macular Edema Production, Consumption, Export, Import by Regions (2011-2016)
    4.6 Southeast Asia Drugs for Diabetic Macular Edema Production, Consumption, Export, Import by Regions (2011-2016)
    4.7 India Drugs for Diabetic Macular Edema Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Drugs for Diabetic Macular Edema Production, Revenue (Value), Price Trend by Type
    5.1 Global Drugs for Diabetic Macular Edema Production and Market Share by Type (2011-2016)
    5.2 Global Drugs for Diabetic Macular Edema Revenue and Market Share by Type (2011-2016)
    5.3 Global Drugs for Diabetic Macular Edema Price by Type (2011-2016)
    5.4 Global Drugs for Diabetic Macular Edema Production Growth by Type (2011-2016)

6 Global Drugs for Diabetic Macular Edema Market Analysis by Application
    6.1 Global Drugs for Diabetic Macular Edema Consumption and Market Share by Application (2011-2016)
    6.2 Global Drugs for Diabetic Macular Edema Consumption Growth Rate by Application (2011-2016)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Drugs for Diabetic Macular Edema Manufacturers Profiles/Analysis
    7.1 Roche
        7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.1.2 Drugs for Diabetic Macular Edema Product Type, Application and Specification
            7.1.2.1 Type I
            7.1.2.2 Type II
        7.1.3 Roche Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.1.4 Main Business/Business Overview
    7.2 Pfizer
        7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.2.2 Drugs for Diabetic Macular Edema Product Type, Application and Specification
            7.2.2.1 Type I
            7.2.2.2 Type II
        7.2.3 Pfizer Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.2.4 Main Business/Business Overview
    7.3 Genentech
        7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.3.2 Drugs for Diabetic Macular Edema Product Type, Application and Specification
            7.3.2.1 Type I
            7.3.2.2 Type II
        7.3.3 Genentech Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.3.4 Main Business/Business Overview
    7.4 ActiveSite Pharmaceuticals
        7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.4.2 Drugs for Diabetic Macular Edema Product Type, Application and Specification
            7.4.2.1 Type I
            7.4.2.2 Type II
        7.4.3 ActiveSite Pharmaceuticals Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.4.4 Main Business/Business Overview
    7.5 Acucela
        7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.5.2 Drugs for Diabetic Macular Edema Product Type, Application and Specification
            7.5.2.1 Type I
            7.5.2.2 Type II
        7.5.3 Acucela Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.5.4 Main Business/Business Overview
    7.6 Aerpio Therapeutics
        7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.6.2 Drugs for Diabetic Macular Edema Product Type, Application and Specification
            7.6.2.1 Type I
            7.6.2.2 Type II
        7.6.3 Aerpio Therapeutics Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.6.4 Main Business/Business Overview
    7.7 Allergan
        7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.7.2 Drugs for Diabetic Macular Edema Product Type, Application and Specification
            7.7.2.1 Type I
            7.7.2.2 Type II
        7.7.3 Allergan Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.7.4 Main Business/Business Overview
    7.8 Ampio Pharmaceuticals
        7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.8.2 Drugs for Diabetic Macular Edema Product Type, Application and Specification
            7.8.2.1 Type I
            7.8.2.2 Type II
        7.8.3 Ampio Pharmaceuticals Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.8.4 Main Business/Business Overview
    7.9 Dyax
        7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.9.2 Drugs for Diabetic Macular Edema Product Type, Application and Specification
            7.9.2.1 Type I
            7.9.2.2 Type II
        7.9.3 Dyax Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.9.4 Main Business/Business Overview
    7.10 EyeGate Pharmaceuticals
        7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.10.2 Drugs for Diabetic Macular Edema Product Type, Application and Specification
            7.10.2.1 Type I
            7.10.2.2 Type II
        7.10.3 EyeGate Pharmaceuticals Drugs for Diabetic Macular Edema Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.10.4 Main Business/Business Overview
    7.11 Gene Signal International

8 Drugs for Diabetic Macular Edema Manufacturing Cost Analysis
    8.1 Drugs for Diabetic Macular Edema Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Drugs for Diabetic Macular Edema

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Drugs for Diabetic Macular Edema Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Drugs for Diabetic Macular Edema Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Drugs for Diabetic Macular Edema Market Forecast (2016-2021)
    12.1 Global Drugs for Diabetic Macular Edema Capacity, Production, Revenue Forecast (2016-2021)
    12.2 Global Drugs for Diabetic Macular Edema Production, Consumption Forecast by Regions (2016-2021)
    12.3 Global Drugs for Diabetic Macular Edema Production Forecast by Type (2016-2021)
    12.4 Global Drugs for Diabetic Macular Edema Consumption Forecast by Application (2016-2021)
    12.5 Drugs for Diabetic Macular Edema Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
    Author List
    Disclosure Section
    Research Methodology
    Data Source
    China Disclaimer